![Annalisa D’Andrea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Annalisa D’Andrea
Direktor/Vorstandsmitglied bei
Engimmune Therapeutics AG
Profil
Annalisa D’Andrea currently works at Engimmune Therapeutics AG, as Non-Executive Director from 2023 and Longwood Fund Management LLC, as Venture Partner from 2021.
Dr. D’Andrea also formerly worked at SRI International, as Executive Director & Head-Discovery Biology, Roche Holding AG, as Vice President & Global Head-Discovery, Kiniksa Pharmaceuticals Ltd., as Chief Scientific Officer, and ImmuneID, Inc., as President & Chief Scientific Officer.
Dr. D’Andrea received her doctorate degree from the University of Florence and undergraduate degree from the University of Siena.
Aktive Positionen von Annalisa D’Andrea
| Unternehmen | Position | Beginn |
|---|---|---|
Engimmune Therapeutics AG
 Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Direktor/Vorstandsmitglied | 24.05.2023 |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Private Equity Investor | 01.03.2021 |
Ehemalige bekannte Positionen von Annalisa D’Andrea
| Unternehmen | Position | Ende |
|---|---|---|
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Präsident | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Direktor/Vorstandsmitglied | - |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Annalisa D’Andrea
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
University of Florence
 University of Florence Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Siena
 University of Siena Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Engimmune Therapeutics AG
Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Health Technology |
